{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:44:33Z","timestamp":1792759473858,"version":"4.5.0"},"reference-count":17,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Chromatography"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Specificity assessment is essential in bioanalytical method development to ensure accurate analyte quantification in the presence of endogenous matrix components and potential exogenous interferences. Regulatory expectations have evolved over time, culminating in the harmonized ICH M10 guideline, which establishes a globally aligned framework for bioanalytical method validation. Although LC\u2013MS\/MS provides high analytical specificity, challenges remain, particularly from isobaric interferences and increasingly complex multi\u2010analyte assays. A common practical issue is trace contamination of authentic reference standards, such as parent drug in metabolite standards or vice versa, which can generate unacceptable cross\u2010signal contributions and compromise specificity assessments. When such impurities preclude conventional specificity testing, this perspective discusses scientifically justified approaches, including predetermined baseline corrections to account for contaminated standards. It also highlights incurred sample reanalysis (ISR) as a more meaningful assessment of assay specificity under these constrained conditions because it reflects the true in\u00a0vivo composition of parent drug and metabolites. The application of ISR has emerged as a robust, regulatory\u2010endorsed tool for confirming assay reliability over time and, as such, could also serve as an alternative for some of the issues discussed.<\/jats:p>","DOI":"10.1002\/bmc.70643","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:35:58Z","timestamp":1792409758000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Specificity Testing in Bioanalytical Assay Validations\u2014Challenges and Opportunities"],"prefix":"10.1002","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1935-3677","authenticated-orcid":false,"given":"Raja Reddy","family":"Kallem","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology and Pharmacometrics Lundbeck Pharmaceuticals LLC  Deerfield Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0626-3234","authenticated-orcid":false,"given":"Michael G.","family":"Bartlett","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy University of Georgia  Athens Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuggehally R.","family":"Srinivas","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Pharmacometrics Lundbeck Pharmaceuticals LLC  Deerfield Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0731\u20107085(95)01634\u20101"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.15.159"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio\u20102019\u20100150"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.6461"},{"key":"e_1_2_6_6_1","volume-title":"Guideline on Bioanalytical Method Validation","author":"European Medicines Agency (EMA)","year":"2011"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248\u2010009\u20109100\u20109"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248\u2010014\u20109644\u20101"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio\u20102022\u20100138"},{"key":"e_1_2_6_10_1","volume-title":"Guideline on Bioanalytical Method Validation and Study Sample Analysis","author":"International Council for Harmonisation (ICH) M10","year":"2022"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.6079"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.70023"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.447"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.594"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5843"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.70236"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.1790"},{"key":"e_1_2_6_18_1","volume-title":"Bioanalytical Method Validation Guidance for Industry","author":"Center for Drug Evaluation and Research, US FDA","year":"2018"}],"container-title":["Biomedical Chromatography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bmc.70643","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bmc.70643","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bmc.70643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:07:02Z","timestamp":1792757222000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/bmc.70643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10.1002\/bmc.70643"],"URL":"https:\/\/doi.org\/10.1002\/bmc.70643","archive":["Portico"],"relation":{},"ISSN":["0269-3879","1099-0801"],"issn-type":[{"value":"0269-3879","type":"print"},{"value":"1099-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"2026-07-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70643"}}